Dermatology· Topic 3.3 Vascular dermatoses· 3.3.9

Pyoderma gangrenosum

Pyoderma gangrenosum is a rare neutrophilic ulcerative disease that begins as a tender pustule or nodule and rapidly evolves into a painful ulcer with a violaceous, undermined border, most often in patients with inflammatory bowel disease, inflammatory arthritis, or a hematologic disorder. Diagnosis is clinical and by exclusion after biopsy and culture; first-line treatment is systemic glucocorticoids or cyclosporine, and debridement must be avoided because of pathergy.

10 min read1 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: pyoderma gangrenosum (PG) is a rare, painful ulcerative neutrophilic disease of the skin of unknown origin, classified alongside Sweet syndrome as a neutrophilic dermatosis.

  • Epidemiology

    Rarity: the estimated prevalence in the United States is 5.8 patients per 100,000 adults.

  • Risk factors

    Inflammatory bowel disease: the single most common systemic association, with skin lesions occurring in roughly 10% of patients with inflammatory bowel disease as one of erythema nodosum, pyoderma gangrenosum, or aphthous ulcers.

  • Pathophysiology

    Neutrophilic infiltrate: histopathology classically shows a pandermal infiltrate predominantly composed of neutrophils with associated dermal edema, without evidence of true vasculitis or infection.

  • Clinical features

    Diagnostic lesion morphology: a tender nodule or pustule rapidly progresses to a painful ulcer with a ragged, undermined, violaceous or gunmetal-colored border and a purulent, exudative base…

  • Differential diagnosis

    Venous ulcer: typically at the medial malleolus, shallow and irregular with weeping exudate and variable pain that improves with leg elevation, unlike the exquisitely painful, violaceous, undermined border of pyoderma gangrenosum.

  • Diagnosis

    Diagnostic basis: pyoderma gangrenosum is a clinical diagnosis of exclusion, established by the characteristic painful ulcer with a violaceous, undermined border after infection and malignancy have…

  • Management

    First step for every active lesion: do not debride the ulcer; sharp debridement of devitalized tissue helps most other ulcers but worsens pyoderma gangrenosum through pathergy.

  • Complications

    Deep tissue exposure: rapidly enlarging ulcers can expose underlying tendon or muscle, particularly when the diagnosis is missed and inappropriate debridement worsens the wound.

  • Prognosis

    Course tracks the associated disease loosely: in inflammatory bowel disease, PG typically follows an independent course from bowel disease activity, so colitis control alone does not guarantee skin improvement.

  • Prevention

    Avoid elective trauma to skin in patients with known pyoderma gangrenosum, including unnecessary surgery, biopsies, or piercings, given the 20 to 30% risk of pathergy-induced new lesions.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.